Philadelphia Trust Company’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-70,664
Closed -$2.87M 213
2017
Q2
$2.87M Sell
70,664
-2,420
-3% -$75K 0.24% 80
2017
Q1
$1.47M Sell
73,084
-3,350
-4% -$70.9K 0.12% 107
2016
Q4
$1.76M Sell
76,434
-2,190
-3% -$46.9K 0.14% 97
2016
Q3
$1.59M Buy
78,624
+2,600
+3% +$52.4K 0.14% 99
2016
Q2
$1.43M Sell
76,024
-60,716
-44% -$1.12M 0.12% 98
2016
Q1
$2.45M Buy
136,740
+109,790
+407% +$1.88M 0.21% 71
2015
Q4
$455K Sell
26,950
-500
-2% -$8.4K 0.04% 138
2015
Q3
$442K Buy
+27,450
New +$460K 0.04% 131

Other funds holding PETS

Philadelphia Trust Company's PETS Position: Q3 2017 in Review

Philadelphia Trust Company sold out of PetMed Express (PETS) in Q3 2017, closing a stake of 70,664 shares — an estimated $2.87M sold.

Philadelphia Trust Company first reported a position in PETS in Q3 2015 and held it in 8 quarters. The position peaked at $2.87M in Q2 2017. 179 funds tracked by Wall St. Rank hold PETS as of Q3 2017.

  • Philadelphia Trust Company reported no remaining PetMed Express position as of Q3 2017 after selling out during the quarter.
  • Philadelphia Trust Company sold 70,664 PetMed Express shares in Q3 2017, an estimated $2.87M.
  • Philadelphia Trust Company first reported a position in PetMed Express in Q3 2015 and held it in 8 quarters.
  • Philadelphia Trust Company's PetMed Express position peaked at $2.87M in Q2 2017.
  • 179 funds tracked by Wall St. Rank held PetMed Express as of Q3 2017.

Based on Philadelphia Trust Company's 13F filing for Q3 2017, filed 13 Nov 2017.